An Analysis of Mindfulness-Based Cognitive Therapy as an Effective Adjuvant in Depression Treatment
Communications in Humanities Research May 30, 2025 DOI: 10.54254/2753-7064/2024.23434 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Randomized Peer reviewed |
|---|---|
| Intervention | Mindfulness-based cognitive therapy (MBCT) |
| Topics | Depression Meditation |
| Key findings | The authors report that randomized controlled trials show MBCT is effective as an adjuvant treatment for depression and in preventing relapse, and suggest that patients who are more receptive and open-minded toward the therapy are more likely to benefit, even when initial acceptance is low but attitude changes during treatment. They propose that guiding patients in this way could improve outcomes and that future research might allow MBCT to replace drug treatment. |
Abstract
A large number of studies have demonstrated the effectiveness of mindfulness- based cognitive therapy (MBCT) in the adjuvant treatment of depression, and the significant effect of MBCT in inhibiting the recurrence of depression, most of these studies are randomized controlled trials. These studies compared a group of MBCT combined with conventional treatment and conventional treatment to ensure the accuracy of the experimental results. We can see that in the adjuvant treatment of patients with MBCT, those who are more receptive and open-minded to this therapy are more likely to benefit from it. Even if the patient does not accept it initially, changes in the patient's attitude during treatment can allow the treatment to work. If we can guide patients in this way, The treatment of MBCT may achieve a better effect, and further research in the future may enable RCT to play a role alone in the treatment of patients with depression, enabling RCT to replace drug treatment.